Akamine Scott

CIK 00018167201 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001816720

Recent Transactions

20 trades

Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−7,527→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-08-01−367,126→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-08-01−59,171→ 0 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-01-19+59,171→ 59,171 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-20$41.42/sh−7,072→ 7,237 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-12-19−13,796→ 0 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-19+13,796→ 14,309 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-07$41.37/sh−10,000→ 513 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-12-07−10,000→ 254,262 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-07$13.17/sh+10,000→ 10,513 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-05$35.00/sh−7,500→ 513 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-12-05−7,500→ 264,262 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-12-05$13.17/sh+7,500→ 8,013 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-02-06+54,292→ 54,292 total
Award
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2023-02-06+13,796→ 13,796 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2022-08-08$40.00/sh−10,000→ 0 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2022-08-08$13.17/sh+10,000→ 10,000 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-08-08−10,000→ 271,762 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-02-09+58,572→ 58,572 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-06-01+281,762→ 281,762 total

Companies

Cerevel Therapeutics Holdings, Inc.
Chief Legal Officer

Recent Filings

Address

C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200

CAMBRIDGE, MA, 02141

View on SEC.gov